1 APRIL 2010 NEW ZEALAND GAZETTE, No. 39 1109

Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 300µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories (Puerto Rico) Inc., Puerto Rico, United States of America

Dated this 25th day of March 2010.

ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go2385

Classification of Medicines

Pursuant to section 106(1) of the Medicines Act 1981, I, Anthony Hill, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health, acting under delegated authority, hereby declare that:

The medicine listed in the Schedule to this notice is classified as a prescription medicine.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are:

(a) preparations and admixtures containing any proportion of any substance listed in the notice.

(b) salts and esters of any substance listed in the notice.

(c) preparations or extracts of biological materials listed in the notice.

(d) salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference to a medicine applies:

(i) if the medicine is in an injection or eye preparation, to any concentration of that medicine; and

(ii) if the medicine is not in an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.

Schedule

Prescription Medicines

Oseltamivir; except when sold in a pharmacy between the months of April to September inclusive by a registered pharmacist who is satisfied that the medicine is for the treatment of a consumer who is resident in New Zealand, is 12 years of age or more, and currently has the symptoms of influenza.

Inland Revenue

Tax Administration Act 1994

Notice of Revocation of Determination of Tax Depreciation Rates

1. This is a notice of revocation under section 91AAF(6) of the Tax Administration Act 1994 of a depreciation determination issued by the Commissioner of Inland Revenue under section 91AAF of that Act.

Dated this 25th day of March 2010.

ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health.

go2397

Mental Health (Compulsory Assessment and Treatment) Act 1992

Mental Health (Compulsory Assessment and Treatment) Act Notice 2010—Appointment of Directors of Area Mental Health Services

Pursuant to section 92 of the Mental Health (Compulsory Assessment and Treatment) Act 1992, I, Stephen Bruce McKernan, Director-General of Health, give the following notice.

Notice

1. This notice shall be read together with the Mental Health (Compulsory Assessment and Treatment) Notice 2000—Appointment of Directors of Area Mental Health Services (“the principal notice”)*.

2. The Schedule to the principal notice is amended in respect of

   “Area 2—Auckland”

   by omitting the name and title

   “Alexander Ian Fredrick Simpson, medical practitioner of Auckland”

   and substituting the name and title

   “Dr Jeremy Skipworth, medical practitioner of Auckland”.

Dated at Wellington this 24th day of March 2010.

STEPHEN BRUCE MCKERNAN (DR), Director-General of Health.

*New Zealand Gazette, 31 August 2000, No. 117, page 2963

go2473

2. “Determination DEP72: Tax Depreciation Rates General Determination Number 72”, which added the general asset class “Furniture (loose) with a general DV of 20%” into the “Hire Equipment (short term hire of 1 month or less only)” asset category was signed on 30 November 2009.

3. That determination was issued with an incorrect reference number. It is hereby revoked to allow for a replacement determination to be issued.

GARY DICK, Team Manager, Technical Services (Office of the Chief Tax Counsel).

go2511